Who
John Fesko
President, Chief Bus. Officer
Company insider
Files Form 4 as: President, Chief Bus. Officer, Natera.
In numbers
- Trades disclosed
- 88
- Buys
- 0
- Sells
- 39
- Bought
- $0
- Sold
- $25.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Jan 2024
- Last trade
- 10 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 28 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $2.1M6,517 at $321.53 | filing |
| 10 Aug 2026filed 28 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $2.1M6,517 at $321.53 | filing |
| 6 Aug 2026filed 28 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Aug 2026filed 28 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $79K295 at $267.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $79K295 at $267.99 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $237K931 at $254.07 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $237K931 at $254.07 | filing |
| 27 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $204K782 at $260.49 | filing |
| 27 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $204K782 at $260.49 | filing |
| 26 May 2026filed 28 May 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $292K1,438 at $202.84 | filing |
| 26 May 2026filed 28 May 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $292K1,438 at $202.84 | filing |
| 1 May 2026filed 5 May 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $60K291 at $206.16 | filing |
| 1 May 2026filed 5 May 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $60K291 at $206.16 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $157K771 at $203.75 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $187K917 at $204.39 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $157K771 at $203.75 | filing |
| 27 Apr 2026filed 29 Apr 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $187K917 at $204.39 | filing |
| 10 Mar 2026filed 11 Mar 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $144K707 at $204.13 | filing |
| 10 Mar 2026filed 11 Mar 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $144K707 at $204.13 | filing |
News
Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
0 headlines in the last 90 days name John Fesko; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.